Form 8-K AMGEN INC For: Jul 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Amgen, Inc. (AMGN) Tops Q2 EPS by 30c
July 29, 2014 4:16 PM EDTAmgen, Inc. (NASDAQ: AMGN) reported Q2 EPS of $2.37, $0.30 better than the analyst estimate of $2.07. Revenue for the quarter came in at $5.18 billion versus the consensus estimate of $4.9 billion.
Highlights:
Total revenues increased 11 percent to $5,180 million, with 8 percent product sales growth driven by strong performance across the portfolio, particularly Enbrel® (etanercept), Kyprolis® (carfilzomib), Prolia®... More